The strong recent performance of the Magnificent 7 has increased the technology concentration in the S&P 500 Index and even more in the Russell 1000 Growth Index. Professional investors only.
There is increasing interest in the use of continuous glucose monitors (CGMs) for wellness, which extends the appeal of the devices well beyond the diabetic population.